Abstract
Viruses are relatively uncommon but important cause of renal infection. Viral pathogens such as cytomegalovirus (CMV), polyomaviruses (JC or BK virus), and adenoviruses are able to replicate in the kidney, and symptomatic infection with these agents can be associated with significant morbidity and mortality in immunocompromised hosts such as renal allograft recipients. Of these, CMV is a particular problem in kidney transplant recipients and can result in temporary or irreversible renal dysfunction. CMV disease in immunocompromised patients is usually due to reactivation of the latent virus. Renal manifestation of CMV infection may include tubulointerstitial nephritis and glomerulopathy. Classic histologic findings in CMV nephritis include evidence of interstitial nephritis and characteristic “owl’s eyes” representing intracellular inclusions. Antiviral therapy is usually reserved for immunocompromised hosts.
BK polyomaviruses also have tropism for urinary epithelium. Symptomatic renal disease with polyomaviruses has only been described in immunocompromised patients, and clinical manifestations in this patient population may include tubulointerstitial nephritis, ureteral stenosis, and hemorrhagic cystitis. Similar to CMV, renal disease with BK virus in kidney transplant recipients is primarily due to reactivation of the latent virus. BK nephritis should be suspected in patients with allograft dysfunction who are found to have “decoy cells” in urinalysis, and the diagnosis is usually confirmed based on histopathologic findings and BK virus PCR (polymerase chain reaction). Reduction in immunosuppression is the cornerstone of therapy in BK virus nephritis.
Renal infection with adenovirus is rare but has been associated with necrotizing tubulointerstitial nephritis in kidney transplant recipients and hemorrhagic cystitis in bone marrow transplant patients. Other viruses that may cause renal injury include Coxsackie and hantavirus groups.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mandell GL, editor. Mandell: Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2009.
Ustinov JA, Loginov RJ, Mattila PM, et al. Cytomegalovirus infection of human kidney cells in vitro. Kidney Int. 1991; 40(5):954–60.
Heieren MH, Kim YK, Balfour Jr HH. Human cytomegalovirus infection of kidney glomerular visceral epithelial and tubular epithelial cells in culture. Transplantation. 1988;46(3):426–32.
Heieren MH, van der Woude FJ, Balfour Jr HH. Cytomegalovirus replicates efficiently in human kidney mesangial cells. Proc Natl Acad Sci USA. 1988;85(5):1642–6.
van Dorp WT, van Wieringen PA, Marselis-Jonges E, et al. Cytomegalovirus directly enhances MHC class I and intercellular adhesion molecule-1 expression on cultured proximal tubular epithelial cells. Transplantation. 1993;55(6):1367–71.
Osawa R, Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care. 2009;13(3):R68.
Platt JL, Sibley RK, Michael AF. Interstitial nephritis associated with cytomegalovirus infection. Kidney Int. 1985;28(3):550–2.
Kaminska A, Roszkowska-Blaim M, Weglarska J, et al. [Rare causes of interstitial nephritis in two children]. Wiad Lek. 2005;58 Suppl 1:93–7.
Matsukura H, Itoh Y, Kanegane H, Arai M, Miyawaki T, Murakami G. Acute tubulointerstitial nephritis: possible association with cytomegalovirus infection. Pediatr Nephrol. 2006;21(3):442–3.
Chirumamilla SR, He C, Racusen LC, Scheimann AO, Cuffari C. Acute kidney injury in a girl with ulcerative colitis and cytomegalovirus-induced focal segmental glomerular sclerosis. World J Pediatr. 2013;9(1):84–6.
Trimarchi H, Jordan R, Iotti A, et al. Late-onset cytomegalovirus-associated interstitial nephritis in a kidney transplant. Nephron. 2002;92(2):490–4.
Ulrich W, Schlederer MP, Buxbaum P, et al. The histopathologic identification of CMV infected cells in biopsies of human renal allografts. An evaluation of 100 transplant biopsies by in situ hybridization. Pathol Res Pract. 1986;181(6):739–45.
Joshi K, Nada R, Radotra BD, Jha V, Sakhuja V. Pathological spectrum of cytomegalovirus infection of renal allograft recipients-an autopsy study from north India. Indian J Pathol Microbiol. 2004;47(3):327–32.
Ozdemir BH, Sar A, Uyar P, Suren D, Demirhan B, Haberal M. Posttransplant tubulointerstitial nephritis: clinicopathological correlation. Transplant Proc. 2006;38(2):466–9.
Cameron J, Rigby RJ, van Deth AG, Petrie JJ. Severe tubulo-interstitial disease in a renal allograft due to cytomegalovirus infection. Clin Nephrol. 1982;18(6):321–5.
Tiple A, Kamar N, Esposito L, et al. Unusual presentation of cytomegalovirus infection in patients after organ transplant. Exp Clin Transplant. 2009;7(1):45–9.
Castro LA, Gokel JM, Thoenes G, et al. Renal changes in cytomegalovirus infection. Proc Eur Dial Transplant Assoc. 1983; 19:500–4.
Herrera GA, Alexander RW, Cooley CF, et al. Cytomegalovirus glomerulopathy: a controversial lesion. Kidney Int. 1986; 29(3):725–33.
Battegay EJ, Mihatsch MJ, Mazzucchelli L, et al. Cytomegalovirus and kidney. Clin Nephrol. 1988;30(5):239–47.
Birk PE, Chavers BM. Does cytomegalovirus cause glomerular injury in renal allograft recipients? J Am Soc Nephrol. 1997; 8(11):1801–8.
Shorr RI, Longo WL, Oberley TD, Bozdech MJ, Walker DL. Cytomegalovirus-associated tubulointerstitial nephritis in an allogeneic bone marrow transplant recipient. Ann Intern Med. 1987;107(3):351–2.
Razonable RR. Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clin Proc. 2011;86(10):1009–26.
Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet. 1971;1(7712):1253–7.
Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation. 1999;67(1):103–9.
Bratt G, Hammarin AL, Grandien M, et al. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS. 1999;13(9):1071–5.
Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005; 79(10): 1277–86.
Dharnidharka VR, Cherikh WS, Abbott KC. An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation. 2009;87(7):1019–26.
Schold JD, Rehman S, Kayler LK, et al. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int. 2009;22(6):626–34.
Randhawa P, Baksh F, Aoki N, Tschirhart D, Finkelstein S. JC virus infection in allograft kidneys: analysis by polymerase chain reaction and immunohistochemistry. Transplantation. 2001; 71(9):1300–3.
Drachenberg CB, Hirsch HH, Papadimitriou JC, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation. 2007;84(3):323–30.
Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol. 2002;13(8):2145–51.
Gardner SD, MacKenzie EF, Smith C, Porter AA. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol. 1984; 37(5):578–86.
Bohl DL, Brennan DC, Ryschkewitsch C, et al. BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol. 2008;43(2):184–9.
Traystman MD, Gupta PK, Shah KV, et al. Identification of viruses in the urine of renal transplant recipients by cytomorphology. Acta Cytol. 1980;24(6):501–10.
Drachenberg CB, Beskow CO, Cangro CB, et al. Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum Pathol. 1999;30(8):970–7.
Singh HK, Andreoni KA, Madden V, et al. Presence of urinary Haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol. 2009;20(2):416–27.
Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002; 347(7):488–96.
Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med. 2000;342(18):1361–3.
Schmid H, Nitschko H, Gerth J, et al. Polyomavirus DNA and RNA detection in renal allograft biopsies: results from a European multicenter study. Transplantation. 2005;80(5):600–4.
Drachenberg CB, Papadimitriou JC. Polyomavirus-associated nephropathy: update in diagnosis. Transpl Infect Dis. 2006; 8(2):68–75.
Arthur RR, Shah KV. Occurrence and significance of papovaviruses BK and JC in the urine. Prog Med Virol. 1989;36:42–61.
Howell DN, Smith SR, Butterly DW, et al. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. Transplantation. 1999;68(9):1279–88.
Wiseman AC. Polyomavirus nephropathy: a current perspective and clinical considerations. Am J Kidney Dis. 2009; 54(1):131–42.
Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant. 2004;4(12):2082–92.
Buehrig CK, Lager DJ, Stegall MD, et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int. 2003;64(2):665–73.
Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant. 2005;5(3):582–94.
Randhawa P, Brennan DC. BK virus infection in transplant recipients: an overview and update. Am J Transplant. 2006; 6(9):2000–5.
Hardinger KL, Koch MJ, Bohl DJ, Storch GA, Brennan DC. BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant. 2010;10(2):407–15.
Josephson MA, Williams JW, Chandraker A, Randhawa PS. Polyomavirus-associated nephropathy: update on antiviral strategies. Transpl Infect Dis. 2006;8(2):95–101.
Gabardi S, Waikar SS, Martin S, et al. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol. 2010;5(7):1298–304.
Sener A, House AA, Jevnikar AM, et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients. Transplantation. 2006;81(1):117–20.
Casadei DH, del C Rial M, Opelz G, et al. A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation. 2001;71(1):53–8.
Josephson MA, Gillen D, Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation. 2006;81(5):704–10.
Vats A, Shapiro R, Singh Randhawa P, et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation. 2003;75(1):105–12.
Vandercam B, Moreau M, Goffin E, et al. Cidofovir-induced end-stage renal failure. Clin Infect Dis. 1999;29(4):948–9.
Muranyi W, Bahr U, Zeier M, van der Woude FJ. Hantavirus infection. J Am Soc Nephrol. 2005;16(12):3669–79.
Centers for Disease Control and Prevention CDC. Hantavirus pulmonary syndrome—five states, 2006. MMWR Morb Mortal Wkly Rep. 2006;55(22):627–9.
Glass GE, Watson AJ, LeDuc JW, Childs JE. Domestic cases of hemorrhagic fever with renal syndrome in the United States. Nephron. 1994;68(1):48–51.
Takeuchi T, Yamamoto T, Itoh M, et al. Clinical studies on hemorrhagic fever with renal syndrome found in Nagoya City University Medical School. Kidney Int Suppl. 1991;35:S84–7.
Lee JS. Clinical features of hemorrhagic fever with renal syndrome in Korea. Kidney Int Suppl. 1991;35:S88–93.
Miettinen MH, Mäkelä SM, Ala-Houhala IO, et al. Ten-year prognosis of Puumala hantavirus-induced acute interstitial nephritis. Kidney Int. 2006;69(11):2043–8.
Khaiboullina SF, Morzunov SP, St Jeor SC. Hantaviruses: molecular biology, evolution and pathogenesis. Curr Mol Med. 2005; 5(8):773–90.
Papadimitriou M. Hantavirus nephropathy. Kidney Int. 1995; 48(3):887–902.
Cosgriff TM, Lewis RM. Mechanisms of disease in hemorrhagic fever with renal syndrome. Kidney Int Suppl. 1991;35:S72–9.
Temonen M, Mustonen J, Helin H, et al. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol. 1996;78(1):47–55.
Mustonen J, Partanen J, Kanerva M, et al. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 1996;49(1):217–21.
Mustonen J, Partanen J, Kanerva M, et al. Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol. 1998; 47(3):277–9.
Laine O, Mäkelä S, Mustonen J, et al. Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection. Thromb Res. 2010;126(2):154–8.
Puljiz I, Kuzman I, Markotic A, et al. Electrocardiographic changes in patients with haemorrhagic fever with renal syndrome. Scand J Infect Dis. 2005;37(8):594–8.
Mäkelä S, Kokkonen L, Ala-Houhala I, et al. More than half of the patients with acute Puumala hantavirus infection have abnormal cardiac findings. Scand J Infect Dis. 2009;41(1):57–62.
Paakkala A, Kallio T, Huhtala H, et al. Renal ultrasound findings and their clinical associations in nephropathia epidemica. Analysis of quantitative parameters. Acta Radiol. 2002;43(3):320–5.
Mustonen J, Helin H, Pietilä K, et al. Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin Nephrol. 1994;41(3):121–6.
Vapalahti O, Mustonen J, Lundkvist Å, et al. Hantavirus infections in Europe. Lancet Infect Dis. 2003;3(10):653–61.
Bharadwaj M, Nofchissey R, Goade D, Koster F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis. 2000;182(1):43–8.
Saksida A, Duh D, Korva M, Avsic ZT. Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J Infect Dis. 2008;197(5):681–5.
Poljak M, Avsic ZT. Immunohistochemical detection of Hantaan virus antigen in renal tissue from patient with hemorrhagic fever with renal syndrome. Nephron. 1994;67(2):252.
Green W, Feddersen R, Yousef O, et al. Tissue distribution of hantavirus antigen in naturally infected humans and deer mice. J Infect Dis. 1998;177(6):1696–700.
Nichol ST, Spiropoulou CF, Morzunov S, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science. 1993;262(5135):914–7.
Huggins JW, Hsiang CM, Cosgriff TM, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis. 1991;164(6):1119–27.
Miettinen MH, Mäkelä SM, Ala-Houhala IO, et al. The severity of acute Puumala hantavirus infection does not predict the long-term outcome of patients. Nephron Clin Pract. 2010; 116(2):c89–94.
Novo R, Gagnadoux MF, Le Guenno Y, et al. Chronic renal failure after Puumala virus infection. Pediatr Nephrol. 1999; 13(9):934–5.
Rarjacdhvttes BK. Serological studies of adenoviral hepatitis following pediatric liver transplantation. Transplant Proc. 1990; 22(4):1547.
Pacini DL, Collier AM, Henderson FW. Adenovirus infections and respiratory illnesses in children in group day care. J Infect Dis. 1987;156(6):920–7.
Ito M, Hirabayashi N, Uno Y, Nakayama A, Asai J. Necrotizing tubulointerstitial nephritis associated with adenovirus infection. Hum Pathol. 1991;22(12):1225–31.
Akiyama H, Kurosu T, Sakashita C, et al. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis. 2001;32(9):1325–30.
Similä S, Jouppila R, Salmi A, Pohjonen R. Encephalomeningitis in children associated with an adenovirus type 7 epidemic. Acta Paediatr Scand. 1970;59(3):310–6.
de Mezerville MHN, Tellier R, Richardson S, et al. Adenoviral infections in pediatric transplant recipients. Pediatr Infect Dis J. 2006;25(9):815–8.
Echavarria M, Forman M, van Tol MJ, et al. Prediction of severe disseminated adenovirus infection by serum PCR. Lancet. 2001; 358(9279):384–5.
Lion T, Baumgartinger R, Watzinger F, et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood. 2003;102(3):1114–20.
Leruez-Ville M, Minard V, Lacaille F, et al. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis. 2004;38(1):45–52.
Becroft DM. Histopathology of fatal adenovirus infection of the respiratory tract in young children. J Clin Pathol. 1967; 20(4):561–9.
Henry Pinkerton SC. Fatal adenovirus pneumonia in infants: correlation of histologic and electron microscopic observations. Am J Pathol. 1971;65(3):543.
Neofytos D, Ojha A, Mookerjee B, et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant. 2007;13(1):74–81.
Ljungman P, Ribaud P, Eyrich M, et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2003;31(6):481–6.
Vittecoq D, Dumitrescu L, Beaufils H, Deray G. Fanconi syndrome associated with cidofovir therapy. Antimicrob Agents Chemother. 1997;41(8):1846.
Doan ML, Mallory GB, Kaplan SL, et al. Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. J Heart Lung Transplant. 2007;26(9):883–9.
Dagan R, Schwartz RH, Insel RA, Menegus MA. Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: possible therapeutic effect of human immune serum globulin containing specific neutralizing antibody. Pediatr Infect Dis. 1984;3(3):246–51.
Munoz FM, Piedra PA, Demmler GJ. Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis. 1998;27(5):1194–200.
Dalldorf G, Sickles GM. An unidentified, filterable agent isolated from the feces of children with paralysis. Science. 1948; 108(2794):61–2.
Pasch A, Frey FJ. Coxsackie B viruses and the kidney—a neglected topic. Nephrol Dial Transplant. 2006;21(5):1184–7.
Burch G, Harb J. Coxsackie B4 viral infection of the human kidney. J Urol. 1974;112(6):714–22.
Aronson M. Coxsackievirus B5 infections in acute oliguric renal failure. J Infect Dis. 1975;132(3):303–6.
Conaldi P, Biancone L, Bottelli A, et al. Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells. J Virol. 1997;71(12):9180.
Page Y, Serrange C, Revillard J. Letter: Coxsackie B virus infections in kidney transplantation. Nouv Presse Med. 1976; 5(25):1587–8.
Yoshida K, Suzuki J, Suzuki S, Kume K, Mutoh S, Kato K, Suzuki H. Experimental IgA nephropathy induced by coxsackie B 4 virus in mice. Am J Nephrol. 1997;17(1):81–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cummins, N.W., Sohail, M.R. (2014). Cytomegalovirus, BK, and Other Viral Infections of the Kidney. In: Fervenza, F., Lin, J., Sethi, S., Singh, A. (eds) Core Concepts in Parenchymal Kidney Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8166-9_14
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8166-9_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8165-2
Online ISBN: 978-1-4614-8166-9
eBook Packages: MedicineMedicine (R0)